SSI in CS
Not Applicable
Completed
- Conditions
- Surgical site infection
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 284
Inclusion Criteria
Pregnant women scheduled for elective caesarean section
Exclusion Criteria
Refusal of the patient to participate
Known allergy/hypersensitivity to chlorhexidine or povidone-iodine
Immunocompromised patients e.g. patients with HIV, diabetes mellitus, malnourished patients and patients on long term steroid therapy
Previous midline scar
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of antiseptic agents in preventing surgical site infections during caesarean sections?
How does the efficacy of PACTR201401000697382 compare to standard-of-care antiseptics like chlorhexidine and povidone-iodine in CS procedures?
What biomarkers are associated with susceptibility to surgical site infections in caesarean section patients?
What are the potential adverse events and optimal management strategies for antiseptic skin preparation in obstetric surgery?
How do combination antiseptic approaches compare to single-agent protocols in reducing postpartum surgical site infections?